Efficacy and safety of tirofiban in high-risk patients with non-ST-segment elevation acute coronary syndromes. [electronic resource]
Producer: 20091123Description: E40-4 p. digitalISSN:- 1932-8737
- Acute Coronary Syndrome -- drug therapy
- Aged
- Angioplasty, Balloon, Coronary -- adverse effects
- Biomarkers -- blood
- Creatine Kinase, MB Form -- blood
- Double-Blind Method
- Electrocardiography
- Female
- Heart Diseases -- blood
- Hemorrhage -- chemically induced
- Humans
- Male
- Middle Aged
- Platelet Aggregation -- drug effects
- Platelet Aggregation Inhibitors -- adverse effects
- Prospective Studies
- Risk Assessment
- Thrombocytopenia -- chemically induced
- Time Factors
- Tirofiban
- Treatment Outcome
- Troponin I -- blood
- Tyrosine -- adverse effects
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.